Barclays’s KALA BIO KALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-445
| Closed | -$31K | – | 4820 |
|
|
2022
Q1 | $31K | Sell |
445
-1,016
| -70% | -$70.8K | ﹤0.01% | 4183 |
|
|
2021
Q4 | $88K | Buy |
1,461
+779
| +114% | +$46.9K | ﹤0.01% | 2978 |
|
|
2021
Q3 | $88K | Buy |
682
+206
| +43% | +$26.6K | ﹤0.01% | 3263 |
|
|
2021
Q2 | $125K | Sell |
476
-722
| -60% | -$190K | ﹤0.01% | 3065 |
|
|
2021
Q1 | $403K | Buy |
1,198
+938
| +361% | +$316K | ﹤0.01% | 2771 |
|
|
2020
Q4 | $88K | Sell |
260
-315
| -55% | -$107K | ﹤0.01% | 3008 |
|
|
2020
Q3 | $218K | Sell |
575
-2,620
| -82% | -$993K | ﹤0.01% | 2694 |
|
|
2020
Q2 | $1.68M | Buy |
3,195
+2,898
| +976% | +$1.52M | ﹤0.01% | 1591 |
|
|
2020
Q1 | $131K | Sell |
297
-152
| -34% | -$67K | ﹤0.01% | 2709 |
|
|
2019
Q4 | $83K | Buy |
449
+182
| +68% | +$33.6K | ﹤0.01% | 3484 |
|
|
2019
Q3 | $50K | Sell |
267
-53
| -17% | -$9.93K | ﹤0.01% | 3679 |
|
|
2019
Q2 | $102K | Buy |
320
+170
| +113% | +$54.2K | ﹤0.01% | 3583 |
|
|
2019
Q1 | $61K | Buy |
150
+109
| +266% | +$44.3K | ﹤0.01% | 3559 |
|
|
2018
Q4 | $10K | Sell |
41
-86
| -68% | -$21K | ﹤0.01% | 3546 |
|
|
2018
Q3 | $62K | Sell |
127
-60
| -32% | -$29.3K | ﹤0.01% | 3652 |
|
|
2018
Q2 | $129K | Buy |
187
+74
| +65% | +$51K | ﹤0.01% | 2958 |
|
|
2018
Q1 | $89K | Buy |
113
+42
| +59% | +$33.1K | ﹤0.01% | 3216 |
|
|
2017
Q4 | $65K | Sell |
71
-168
| -70% | -$154K | ﹤0.01% | 3219 |
|
|
2017
Q3 | $273K | Buy |
+239
| New | +$273K | ﹤0.01% | 2232 |
|